The killing and postantibiotic effects (PAE) of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli were determined in Mueller-Hinton broth (MHB) and pooled human cerebrospinal fluid (CSF). MICs performed in MHB and CSF were within one dilution for all antimicrobial agent-organism combinations. At two times the MIC, CSF significantly (P < 0.05) increased the duration of the PAE compared with MHB when cefotaxime, ciprofloxacin, and gentamicin were used against all strains tested. This effect occurred despite similar reductions in bacterial growth in both fluids after the 2-h antimicrobial agent exposure. We conclude that pooled human CSF markedly increases the PAE of cefotaxime, ciprofloxacin, and gentamicin against E.
The practice of designing antimicrobial agent dosing regimens to maintain concentrations in serum above the MIC for common organisms within the antimicrobial spectrum of activity for the majority of the dosing interval has recently been questioned (1) . Investigators suggest that pharmacodynamic parameters such as the kinetics of bacterial killing and the postantibiotic effect (PAE) provide better parameters than the MIC and MBC in describing the time course of antimicrobial activity. Although the PAE (time period of no growth of the target organism after removal of the antimicrobial agent [2, 15] ) has been investigated for over 40 years (12) , it has only been recently that researchers have realized the clinical significance of this phenomenon. For agents such as aminoglycosides that display concentration-dependent bacterial killing, a prolonged and dose-dependent PAE (17) , and activity at subinhibitory concentrations, new dosage regimens have been suggested (6, 14) .
The majority of in vitro data regarding the PAE have been performed with standard microbiological media such as Mueller-Hinton broth (MHB) (13, 17) . However, the PAE requires study in fluids such as serum, urine, and cerebrospinal fluid (CSF) to more fully assess its biological significance. We have recently described major effects on the PAE by human serum (3) and human urine (16) , and this study represents preliminary observations of effects of pooled human CSF.
One clinical (G1307) and one reference (ATCC 25922) strain of Escherichia coli were used. The clinical isolate was obtained from an adult patient with meningitis. Isolates were frozen (-70°C) in skim milk and transferred onto blood agar plates monthly. At weekly intervals, isolates were subcultured onto fresh blood agar plates and streaked for purity.
The antimicrobial agents used included cefotaxime (Hoechst-Roussel Pharmaceuticals, Montreal, Canada), ciprofloxacin (Miles Pharmaceuticals, Etobicoke, Canada), and gentamicin (Schering Corp. Ltd., Pointe-Claire, Canada). (10) . To obtain such a culture, two or three colonies were inoculated into 50 ml of MHB or 10 ml of CSF-MHB and incubated at 37°C for approximately 12 to 14 h. Before each experiment, 5 ml of this culture was transferred into 45 ml of MHB or 1 ml was transferred into 9 ml of CSF-MHB (optical density at 580 nm, <0.05) and allowed to grow for several hours until the optical density at 580 nm reached 0.3. All optical densities were measured with a Spectronic 1201 Spectrophotometer (Milton Roy, Rochester, N.Y.). The culture was then diluted 1:10 by the addition of 1 ml of this suspension to 9.0 ml of the antimicrobial agent-containing (test) or control medium. This procedure resulted in a final concentration of approximately 106 to 107 CFU/ml. This point was defined as the initial time of exposure to the antimicrobial agent. Counts of CFU were performed immediately to verify the original inoculum. After 2 h of exposure, the antimicrobial agent was removed with a 1:100 dilution by the addition of 0.1 ml of antimicrobial agent-organism solution into 9.9 ml of prewarmed MHB. The following controls were maintained during experiments: (i) a growth control prepared in a manner similar to that used for the test solution without exposure to antimicrobial agents, and (ii) a residual antimicrobial agent control. The residual antimicrobial agent control was designed to ensure the 1:100 dilution reduced the antimicrobial agent to inactive concentrations. The growth control and the residual antimicrobial agent control were treated in the same manner as the test solution. Counts of CFU were made for the test culture and growth control before exposure to antimicrobial agents, after 2 h of exposure, and after dilution to remove the antimicrobial agent. Thereafter, all cultures including the test, growth control, and residual antimicrobial agent control were assessed for growth every 60 min until marked turbidity was noticed. Serial 10-fold dilutions were prepared by using sterile cold 0.85% NaCl. Aliquots of 0.01 and/or 0.1 ml of the appropriate dilutions were plated by using a spread plate technique. Plates were read after 18 to 24 h of incubation at 37°C. The PAE was measured as previously described (10) . The following calculation was used to quantitate the PAE: PAE = T -C, where T = time (minutes) required for the count of CFU in the test culture to increase 1 log1o unit above the count immediately after dilution and where C = time (minutes) required for the count of CFU in the control to increase 1 log1o unit above the count immediately after dilution.
To assess whether antimicrobial agents, which may have been present in the CSF as a result of patient treatment, had been removed after passing through nonionic and cationic resins, 100 pl of CSF was added to blood agar plates seeded with bacteria. CSF added to bacterium-seeded plates before passage through resins demonstrated a marked (50 by 50 mm) zone of inhibition for all tested isolates. After passing through resins, no zone of inhibition was observed with any isolate, suggesting that antimicrobial agents which were present prior to resin treatment had been removed. Analysis of aminoglycoside concentration in CSF after resin treatment by using the TDX Analyzer demonstrated that aminoglycosides, if present, were present at concentrations of <0.1 mg/liter. This level represents the lowest possible concentration which can be detected and suggests that resin treatment removed aminoglycosides present prior to resin treatment. CSF were very similar. In each case, the growth controls increased 1 log unit approximately 80 to 100 min after dilution. In addition, the residual antimicrobial agent controls included in both MHB and CSF experiments grew at the same rate as that of the growth controls, indicating that a 1:100 dilution was effective in removing the activity of the antimicrobial agents.
Results of PAE determinations for cefotaxime, ciprofloxacin, and gentamicin are displayed in Table 2 CSF originates from the choroid plexus of the ventricles, and its composition is derived from filtration, differential absorption, and active secretion (5) . Most constituents in the CSF are present in equal or lower concentrations than in plasma (4, 5, (7) (8) (9) . The concentration of most of the CSF electrolytes varies with changes in concentrations in plasma, but some appear to be independent. Almost all the proteins normally ptesent in CSF are derived from the serum, with the exception of the trace proteins which originate in the brain. Since the majority of the protein in the CSF is derived from the serum, one could speculate that the mechanism of the increased PAE due to CSF would be similar to 
